Cosmo Pharmaceuticals N.V. (COPN.SW)
CHF 45.85
(-3.37%)
CHF 45.85
(-3.37%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -0.31 EUR | -129.52% |
| 2022 | 1.05 EUR | -18.6% |
| 2021 | 1.29 EUR | 334.55% |
| 2020 | -0.55 EUR | 67.07% |
| 2019 | -1.67 EUR | -39.17% |
| 2018 | -1.20 EUR | 45.21% |
| 2017 | -2.19 EUR | -259.85% |
| 2016 | 1.37 EUR | -92.22% |
| 2015 | 17.60 EUR | 243.75% |
| 2014 | 5.12 EUR | 6.44% |
| 2013 | 4.81 EUR | 241.13% |
| 2012 | 1.41 EUR | 166.04% |
| 2011 | 0.53 EUR | 112.0% |
| 2010 | 0.25 EUR | -16.67% |
| 2009 | 0.30 EUR | -55.88% |
| 2008 | 0.68 EUR | 7716.09% |
| 2007 | 0.01 EUR | 155.41% |
| 2006 | -0.02 EUR | -104.76% |
| 2005 | 0.33 EUR | 134.38% |
| 2004 | -0.96 EUR | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | 2.35 EUR | 0.0% |
| 2024 Q1 | 2.35 EUR | 1275.0% |
| 2023 Q1 | 0.05 EUR | -84.14% |
| 2023 Q2 | 0.05 EUR | 0.0% |
| 2023 Q3 | -0.20 EUR | -534.78% |
| 2023 Q4 | -0.20 EUR | 0.0% |
| 2023 FY | - EUR | -129.52% |
| 2022 Q1 | 0.24 EUR | -66.2% |
| 2022 FY | - EUR | -18.6% |
| 2022 Q4 | 0.29 EUR | 0.0% |
| 2022 Q3 | 0.29 EUR | 20.83% |
| 2022 Q2 | 0.24 EUR | 0.0% |
| 2021 Q4 | 0.71 EUR | 0.0% |
| 2021 Q3 | 0.71 EUR | 455.0% |
| 2021 Q1 | -0.20 EUR | -17.65% |
| 2021 FY | - EUR | 334.55% |
| 2021 Q2 | -0.20 EUR | 0.0% |
| 2020 Q1 | -0.10 EUR | 23.08% |
| 2020 FY | - EUR | 67.07% |
| 2020 Q3 | -0.17 EUR | -70.0% |
| 2020 Q4 | -0.17 EUR | 0.0% |
| 2020 Q2 | -0.10 EUR | 0.0% |
| 2019 Q3 | -0.13 EUR | 81.43% |
| 2019 Q2 | -0.70 EUR | 0.0% |
| 2019 Q1 | -0.70 EUR | -105.88% |
| 2019 Q4 | -0.13 EUR | 0.0% |
| 2019 FY | - EUR | -39.17% |
| 2018 Q3 | -0.34 EUR | -30.77% |
| 2018 Q1 | -0.26 EUR | 48.0% |
| 2018 FY | - EUR | 45.21% |
| 2018 Q2 | -0.26 EUR | 0.0% |
| 2018 Q4 | -0.34 EUR | 0.0% |
| 2017 Q3 | -0.50 EUR | 15.25% |
| 2017 Q4 | -0.50 EUR | 0.0% |
| 2017 FY | - EUR | -259.85% |
| 2017 Q1 | -0.59 EUR | -220.41% |
| 2017 Q2 | -0.59 EUR | 0.0% |
| 2016 FY | - EUR | -92.22% |
| 2016 Q4 | 0.49 EUR | 0.0% |
| 2016 Q3 | 0.49 EUR | 157.89% |
| 2016 Q2 | 0.19 EUR | 0.0% |
| 2016 Q1 | 0.19 EUR | -32.14% |
| 2015 Q2 | 8.25 EUR | 0.0% |
| 2015 FY | - EUR | 243.75% |
| 2015 Q4 | 0.28 EUR | 0.0% |
| 2015 Q1 | 8.25 EUR | 6975.0% |
| 2015 Q3 | 0.28 EUR | -96.61% |
| 2014 Q2 | 2.63 EUR | 0.0% |
| 2014 Q4 | -0.12 EUR | 0.0% |
| 2014 Q1 | 2.63 EUR | 1284.21% |
| 2014 Q3 | -0.12 EUR | -104.56% |
| 2014 FY | - EUR | 6.44% |
| 2013 FY | - EUR | 241.13% |
| 2013 Q4 | 0.19 EUR | 0.0% |
| 2013 Q1 | 2.14 EUR | 9496.41% |
| 2013 Q2 | 2.14 EUR | 0.0% |
| 2013 Q3 | 0.19 EUR | -91.12% |
| 2012 Q4 | 0.02 EUR | 0.0% |
| 2012 Q3 | 0.02 EUR | -93.63% |
| 2012 FY | - EUR | 166.04% |
| 2012 Q1 | 0.35 EUR | 0.0% |
| 2012 Q2 | 0.35 EUR | 0.0% |
| 2011 Q3 | 0.13 EUR | 0.0% |
| 2011 Q1 | 0.13 EUR | 0.0% |
| 2011 Q2 | 0.13 EUR | 0.0% |
| 2011 FY | - EUR | 112.0% |
| 2011 Q4 | 0.35 EUR | 169.23% |
| 2010 FY | - EUR | -16.67% |
| 2010 Q3 | 0.06 EUR | 0.0% |
| 2010 Q2 | 0.06 EUR | 0.0% |
| 2010 Q1 | 0.06 EUR | 0.0% |
| 2010 Q4 | 0.13 EUR | 110.7% |
| 2009 Q1 | 0.07 EUR | 0.0% |
| 2009 FY | - EUR | -55.88% |
| 2009 Q4 | 0.06 EUR | -16.4% |
| 2009 Q3 | 0.07 EUR | 0.0% |
| 2009 Q2 | 0.07 EUR | 0.0% |
| 2008 FY | - EUR | 7716.09% |
| 2008 Q4 | 0.07 EUR | -56.59% |
| 2008 Q2 | 0.17 EUR | 0.0% |
| 2008 Q1 | 0.17 EUR | 0.0% |
| 2008 Q3 | 0.17 EUR | 0.0% |
| 2007 FY | - EUR | 155.41% |
| 2007 Q4 | 0.17 EUR | 7627.27% |
| 2007 Q3 | 0.00 EUR | 0.0% |
| 2007 Q2 | 0.00 EUR | 0.0% |
| 2007 Q1 | 0.00 EUR | 0.0% |
| 2006 Q1 | -0.00 EUR | 0.0% |
| 2006 Q4 | 0.00 EUR | 156.41% |
| 2006 FY | - EUR | -104.76% |
| 2006 Q2 | -0.00 EUR | 0.0% |
| 2006 Q3 | -0.00 EUR | 0.0% |
| 2005 Q2 | 0.08 EUR | 0.0% |
| 2005 Q3 | 0.08 EUR | 0.0% |
| 2005 Q1 | 0.08 EUR | 0.0% |
| 2005 Q4 | -0.00 EUR | -104.74% |
| 2005 FY | - EUR | 134.38% |
| 2004 Q4 | 0.08 EUR | 134.25% |
| 2004 FY | - EUR | 0.0% |
| 2004 Q1 | -0.24 EUR | 0.0% |
| 2004 Q2 | -0.24 EUR | 0.0% |
| 2004 Q3 | -0.24 EUR | 0.0% |
| 2003 Q4 | -0.24 EUR | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Roche Holding AG | 14.31 CHF | 102.166% |
| Roche Holding AG | 14.31 CHF | 102.166% |